Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT.
Standard
Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT. / Derlin, Thorsten; Clauditz, Till; Quaas, Alexander; Habermann, Christian.
in: CLIN NUCL MED, Jahrgang 37, Nr. 10, 10, 2012, S. 255-256.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Synchronous bronchioloalveolar and squamous cell lung cancer with different 18F-FDG avidity on PET/CT.
AU - Derlin, Thorsten
AU - Clauditz, Till
AU - Quaas, Alexander
AU - Habermann, Christian
PY - 2012
Y1 - 2012
N2 - We report a case of synchronous multiple primary lung cancer diagnosed by 18F-FDG PET/CT. A 78-year-old man underwent staging FDG PET/CT that demonstrated intense tracer uptake in the primary, and a second lesion with low uptake. Histopathologic evaluation revealed synchronous squamous cell and bronchioloalveolar carcinoma, representing 2 distinct primaries. FDG PET/CT may identify and diagnose synchronous multiple primary lung cancer on the basis of different morphologic and metabolic features of distinct tumor entities. Moreover, pulmonary lesions with low FDG avidity may still represent malignant disease, even in the context of biopsy-proven FDG-avid lung cancer.
AB - We report a case of synchronous multiple primary lung cancer diagnosed by 18F-FDG PET/CT. A 78-year-old man underwent staging FDG PET/CT that demonstrated intense tracer uptake in the primary, and a second lesion with low uptake. Histopathologic evaluation revealed synchronous squamous cell and bronchioloalveolar carcinoma, representing 2 distinct primaries. FDG PET/CT may identify and diagnose synchronous multiple primary lung cancer on the basis of different morphologic and metabolic features of distinct tumor entities. Moreover, pulmonary lesions with low FDG avidity may still represent malignant disease, even in the context of biopsy-proven FDG-avid lung cancer.
KW - Humans
KW - Male
KW - Aged
KW - Biological Transport
KW - Positron-Emission Tomography and Computed Tomography
KW - Fluorodeoxyglucose F18/diagnostic use/metabolism
KW - Adenocarcinoma, Bronchiolo-Alveolar/metabolism/pathology/radionuclide imaging
KW - Lung Neoplasms/metabolism/pathology/radionuclide imaging
KW - Neoplasms, Multiple Primary/metabolism/pathology/radionuclide imaging
KW - Neoplasms, Squamous Cell/metabolism/pathology/radionuclide imaging
KW - Humans
KW - Male
KW - Aged
KW - Biological Transport
KW - Positron-Emission Tomography and Computed Tomography
KW - Fluorodeoxyglucose F18/diagnostic use/metabolism
KW - Adenocarcinoma, Bronchiolo-Alveolar/metabolism/pathology/radionuclide imaging
KW - Lung Neoplasms/metabolism/pathology/radionuclide imaging
KW - Neoplasms, Multiple Primary/metabolism/pathology/radionuclide imaging
KW - Neoplasms, Squamous Cell/metabolism/pathology/radionuclide imaging
M3 - SCORING: Journal article
VL - 37
SP - 255
EP - 256
JO - CLIN NUCL MED
JF - CLIN NUCL MED
SN - 0363-9762
IS - 10
M1 - 10
ER -